# Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer

> **NCT03307564** · NA · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 6 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DEVICE:** TraceIT tissue marker injection

## Key facts

- **NCT ID:** NCT03307564
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-06
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03307564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03307564, "Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03307564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*